ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

CYT

75.17
0.00 (0.00%)
24 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
NYSE:CYT NYSE Ordinary Share
  Price Change % Change Share Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 75.17 0.00 01:00:00

Statement of Changes in Beneficial Ownership (4)

11/12/2015 7:36pm

Edgar (US Regulatory)


FORM 4
[ X ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

FLEMING SHANE D
2. Issuer Name and Ticker or Trading Symbol

CYTEC INDUSTRIES INC/DE/ [ CYT ]
5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

__ X __ Director                      _____ 10% Owner
__ X __ Officer (give title below)      _____ Other (specify below)
Chairman,President & CEO
(Last)          (First)          (Middle)

FIVE GARRET MOUNTAIN PLAZA
3. Date of Earliest Transaction (MM/DD/YYYY)

11/30/2015
(Street)

WOODLAND PARK, NJ 07424
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock   12/9/2015     D    34544.0000   D $75.2500   (1) 0.0000   D    
Common Stock   11/30/2015   (2)   A    526.0000   A $0.0000   (2) 51623.0000   I   Savings Plan  
Common Stock   12/9/2015     D    51623.0000   D $75.2500   (1) 0.0000   I   Savings Plan  
Common Stock   11/30/2015   (3)   J (3)    169.0000   D $0.0000   (3) 49239.0000   I   Supplemental Savings Plan  
Common Stock   12/9/2015     D    49239.0000   D $75.2500   (1) 0.0000   I   Supplemental Savings Plan  

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Deferred Stock Award     (4) 12/9/2015     D         160100.0080      (4)   (4) Common Stock   160100.0080   $75.2500   (4) 0.0000   D    
Option Right to buy   $25.7450   12/9/2015     D         124060.0000      (5) 1/25/2021   (5) Common Stock   124060.0000   $49.5050   (5) 0.0000   D    
Option Right to buy   $44.5400   12/9/2015     D         83624.0000      (5) 1/25/2025   (5) Common Stock   83624.0000   $30.7100   (5) 0.0000   D    
Option Right to buy   $18.7950   12/9/2015     D         164300.0000      (5) 1/27/2020   (5) Common Stock   164300.0000   $56.4550   (5) 0.0000   D    
Option Right to buy   $11.2250   12/9/2015     D         90000.0000      (5) 1/28/2019   (5) Common Stock   90000.0000   $64.0250   (5) 0.0000   D    
Option Right to buy   $44.1350   12/9/2015     D         70328.0000      (5) 1/28/2024   (5) Common Stock   70328.0000   $31.1150   (5) 0.0000   D    
Option Right to buy   $25.1650   12/9/2015     D         99590.0000      (5) 1/29/2022   (5) Common Stock   99590.0000   $50.0850   (5) 0.0000   D    
Option Right to buy   $36.5350   12/9/2015     D         84718.0000      (5) 1/29/2023   (5) Common Stock   84718.0000   $38.7150   (5) 0.0000   D    
Restricted Stock Unit   $0.0000   12/9/2015     D         11617.0000    1/26/2018   (6)   (6) Common Stock   11617.0000   $75.2500   (6) 0.0000   D    
Restricted Stock Unit   $0.0000   12/9/2015     D         11456.0000    1/29/2017   (6)   (6) Common Stock   11456.0000   $75.2500   (6) 0.0000   D    
Restricted Stock Unit   $0.0000   12/9/2015     D         13622.0000    1/30/2016   (6)   (6) Common Stock   13622.0000   $75.2500   (6) 0.0000   D    
Stock Appreciation Right   $26.2400   12/9/2015     D         50000.0000      (5) 1/28/2018   (5) Common Stock   50000.0000   $49.0100   (5) 0.0000   D    
Stock Appreciation Right   $29.1100   12/9/2015     D         40000.0000      (5) 1/30/2017   (5) Common Stock   40000.0000   $46.1400   (5) 0.0000   D    
Stock Appreciation Right   $27.5500   12/9/2015     D         22500.0000      (5) 6/26/2018   (5) Common Stock   22500.0000   $47.7000   (5) 0.0000   D    

Explanation of Responses:
( 1)  Pursuant to the Agreement and Plan of Merger by and among Cytec Industries Inc., Solvay SA and Tulip Acquisition Inc. dated as of July 28, 2015 (as amended, the "Merger Agreement"), each of these shares was cancelled at the effective time of the merger and converted into the right to receive $75.25 in cash , less any applicable tax withholding.
( 2)  Number of shares allocated to employee's account under the Cytec Employees' Saving Plan by reason of employee and employer contributions, employee transfers and dividend reinvestments made during the period of January 1-November 30, 2015. Per share prices range from $42.99 (low) to $74.87 (high).
( 3)  Net decrease in number of shares allocated to employee's account under the Cytec Supplemental Savings Plan by reason of employee and employer contributions, employee transfers and dividend reinvestments made during the period of January 1-November 30, 2015. Per share prices range from $42.99 (low) to $74.87 (high).
( 4)  Pursuant to the Merger Agreement, each right to receive shares of our common stock on a deferred basis ("Deferred Stock Award"), was cancelled and converted into a right to receive an amount in cash equal to the product obtained by multiplying (a) the number of shares underlying the Deferred Stock Award, by (b) the merger consideration of $75.25, less any applicable tax withholding payable at various times in the future depending on the recipient's previous deferral elections, but not before July 1, 2016.
( 5)  Pursuant to the Merger Agreement, each outstanding and unexercised option or stock appreciation right ("SAR"), as applicable, whether vested or unvested, was cancelled at the effective time of the merger in exchange for cash equal to the product obtained by multiplying (a) the number of shares underlying such option or SAR, as applicable, by (b) the excess, if any, of the per share value of the merger consideration of $75.25 over the per share exercise price of the option or SAR, as applicable, less any applicable tax withholding.
( 6)  Pursuant to the Merger Agreement, each outstanding restricted stock unit ("RSU"), was cancelled at the effective time of the merger and converted into the right to receive an amount in cash equal to the product obtained by multiplying (a) the number of shares of underlying such RSU, by (b) the merger consideration of $75.25, less any applicable tax withholding payable without interest on the scheduled vesting date of the RSU, or earlier in some circumstances.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
FLEMING SHANE D
FIVE GARRET MOUNTAIN PLAZA
WOODLAND PARK, NJ 07424
X
Chairman,President & CEO

Signatures
Thomas Irwin, Attorney in Fact 12/11/2015
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

1 Year Cytec Chart

1 Year Cytec Chart

1 Month Cytec Chart

1 Month Cytec Chart